Cancer survival‐related studies have shown that a high AST/ALT ratio is associated with poor outcome of renal cell carcinoma,13 head and neck carcinoma,25 and oral and oropharyngeal carcinoma26 among other cancers. This evidence concerns the gene GPT and head and neck carcinoma.